The use of U-500 in patients with extreme insulin resistance

Diabetes Care. 2005 May;28(5):1240-4. doi: 10.2337/diacare.28.5.1240.

Authors

Elaine Cochran¹, Carla Musso, Phillip Gorden

Affiliation

¹ Clinical Endocrinology Branch, National Institute of Diabetes and Digestive and Kidney Diseases/NIH, 9000 Rockville Pike, Bldg. 10, CRC 6-5940, Bethesda, MD 20892, USA. [email protected]

PMID: 15855601
DOI: 10.2337/diacare.28.5.1240

No abstract available

Publication types

Research Support, U.S. Gov't, P.H.S.
Review

MeSH terms

Diabetes Mellitus, Type 2 / drug therapy*
Humans
Hypoglycemic Agents / administration & dosage*
Hypoglycemic Agents / economics
Insulin / administration & dosage*
Insulin / economics
Insulin Resistance*
Severity of Illness Index

Substances

Hypoglycemic Agents
Insulin